Saturday, December 05, 2015 9:49:26 AM
Dec16 2015: “Roth Capital Partners' Immuno-Oncology Corp. Access Day”, NYC http://tinyurl.com/p8ykuu7
...Peregrine will be 1 of 12 participating companies.
FLYER:
“ROTH Capital Partners Senior Biotechnology Research Analysts; Joe Pantginis, PhD, Elemer Piros, PhD, and Michael Higgins invite you to join us for our Immuno-Oncology Corporate Access Day taking place on Wednesday, Dec. 16, 2015 in NYC.
http://www.meetmax.com/upload/event_35023/ROTH_ImmunoOncology_2015.pdf
http://www.roth.com
Recent CDMO News
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
